Southampton Joint Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Formulary Chapter 8: Malignant disease and immunosuppression -
Full Section
Useful Links
Cancer Drugs Fund List
08.01
Cytotoxic drugs
Drugs for cytotoxic-induced side-effects
08.01.01
Alkylating drugs
08.01.02
Anthracyclines and other cytotoxic antibiotics
08.01.03
Antimetabolites
08.01.04
Vinca alkaloids and etoposide
08.01.05
Other antineoplastic drugs
Platinum compounds
Procarbazine
Protein kinase inhibitors
Taxanes
Topoisomerase I inhibitors
Trabectedin
Tretinoin
08.02
Drugs affecting the immune response
08.02.01
Antiproliferative immunosuppressants
08.02.02
Corticosteroids and other immunosuppressants
08.02.03
Anti-lymphocyte monoclonal antibodies
08.02.04
Other immunomodulating drugs
Interferon Alfa
Interferon beta
Aldesleukin
Lenalidomide, pomalidomide, and thalidomide
08.03
Sex hormones and hormone antagonists in malignant disease
08.03.01
Oestrogens
08.03.02
Progestogens
08.03.03
Androgens
08.03.04
Hormone antagonists
08.03.04.01
Breast cancer
08.03.04.02
Prostate cancer and gonadorelin analogues
Gonadorelin analogues
Anti-androgens
08.03.04.03
Somatostatin analogues